Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Others

Enovix (ENVX) Asset Writedowns and Impairment (2023 - 2024)

Enovix's Asset Writedowns and Impairment history spans 2 years, with the latest figure at $9000.0 for Q4 2024.

For Q4 2024, Asset Writedowns and Impairment changed N/A year-over-year to $9000.0; the TTM value through Dec 2025 reached $3.2 million, down 91.76%, while the annual FY2024 figure was $38.3 million, 767.33% up from the prior year.
Asset Writedowns and Impairment reached $9000.0 in Q4 2024 per ENVX's latest filing, down from $3.1 million in the prior quarter.
In the past five years, Asset Writedowns and Impairment ranged from a high of $35.1 million in Q2 2024 to a low of $9000.0 in Q4 2024.